{"id":57114,"date":"2025-12-11T08:08:24","date_gmt":"2025-12-11T12:08:24","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/eli-lillys-retatrutide-shows-superior-weight-loss-reshaping-obesity-market-dynamics\/57114\/"},"modified":"2025-12-11T08:08:24","modified_gmt":"2025-12-11T12:08:24","slug":"eli-lillys-retatrutide-shows-superior-weight-loss-reshaping-obesity-market-dynamics","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/eli-lillys-retatrutide-shows-superior-weight-loss-reshaping-obesity-market-dynamics\/57114\/","title":{"rendered":"Eli Lilly&#8217;s Retatrutide Shows Superior Weight Loss, Reshaping Obesity Market Dynamics"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/eli-lillys-retatrutide-shows-superior-weight-loss-reshaping-obesity-market-dynamics\/57114\/#Key_Takeaways\" >Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/eli-lillys-retatrutide-shows-superior-weight-loss-reshaping-obesity-market-dynamics\/57114\/#Eli_Lillys_Retatrutide_Delivers_Impressive_Weight_Loss_Results\" >Eli Lilly&#39;s Retatrutide Delivers Impressive Weight Loss Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/eli-lillys-retatrutide-shows-superior-weight-loss-reshaping-obesity-market-dynamics\/57114\/#Altria_Announces_CEO_Transition\" >Altria Announces CEO Transition<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/eli-lillys-retatrutide-shows-superior-weight-loss-reshaping-obesity-market-dynamics\/57114\/#Global_Minimum_Tax_Faces_Chinese_Opposition\" >Global Minimum Tax Faces Chinese Opposition<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/eli-lillys-retatrutide-shows-superior-weight-loss-reshaping-obesity-market-dynamics\/57114\/#Citigroup_Upgrades_Thermo_Fisher_Scientific\" >Citigroup Upgrades Thermo Fisher Scientific<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/eli-lillys-retatrutide-shows-superior-weight-loss-reshaping-obesity-market-dynamics\/57114\/#Market_Overview\" >Market Overview<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways\"><\/span>Key Takeaways<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Eli Lilly&#39;s (<a href=\"\/stock\/LLY\">LLY<\/a>) experimental obesity drug, Retatrutide, demonstrated significant weight loss, with participants losing an average of 28.7% of their body weight (up to 71.2 lbs) in a Phase 3 trial, potentially surpassing existing treatments like Zepbound.<\/strong><\/li>\n<li><strong>The positive trial results for Retatrutide led to a 2.1% <a href=\"https:\/\/stockmarketwatch.com\/movers\/premarket\" data-internallinksmanager029f6b8e52c=\"7\" title=\"Premarket Movers\">premarket<\/a> surge in Eli Lilly shares and caused shares of competitor Novo Nordisk (<a href=\"\/stock\/NVO\">NVO<\/a>) to briefly turn negative, highlighting intense competition in the weight-loss drug market.<\/strong><\/li>\n<li><strong>Altria Group (<a href=\"\/stock\/MO\">MO<\/a>) announced the retirement of CEO Billy Gifford, with Sal Mancuso named as his successor, signaling a leadership transition for the tobacco giant.<\/strong><\/li>\n<li><strong>China is leading objections to a potential reprieve by former President Trump on the global minimum tax, indicating ongoing international financial policy disputes.<\/strong><\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Eli_Lillys_Retatrutide_Delivers_Impressive_Weight_Loss_Results\"><\/span>Eli Lilly&#39;s Retatrutide Delivers Impressive Weight Loss Results<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Eli Lilly and Company (<a href=\"\/stock\/LLY\">LLY<\/a>) has reported overwhelmingly positive topline data from its Phase 3 TRIUMPH-4 trial for Retatrutide, an investigational once-weekly treatment for obesity. The experimental triple agonist shot helped participants with obesity and knee osteoarthritis achieve an average body weight reduction of 28.7% over 68 weeks, with some losing up to 71.2 lbs. This performance reportedly tops that of Lilly&#39;s own Zepbound, an existing weight-loss drug, and has met all primary and key secondary endpoints in the trial.<\/p>\n<p>The news sent Eli Lilly shares up 2.1% in <a href=\"https:\/\/stockmarketwatch.com\/movers\/premarket\" data-internallinksmanager029f6b8e52c=\"7\" title=\"Premarket Movers\">premarket<\/a> trading. The success of Retatrutide also had an immediate impact on competitors, with Novo Nordisk (<a href=\"\/stock\/NVO\">NVO<\/a>) shares briefly turning negative before recovering to trade up 1.8%. Eli Lilly expects to complete seven additional Phase 3 trials for Retatrutide in obesity and type 2 diabetes in 2026. Beyond weight loss, the trial also indicated that Retatrutide provides substantial pain relief for knee osteoarthritis, adding another potential benefit to the drug&#39;s profile.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Altria_Announces_CEO_Transition\"><\/span>Altria Announces CEO Transition<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Altria Group (<a href=\"\/stock\/MO\">MO<\/a>) is undergoing a leadership change as CEO Billy Gifford prepares to retire. Sal Mancuso has been named as his successor. This transition marks a significant development for the tobacco industry giant.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Global_Minimum_Tax_Faces_Chinese_Opposition\"><\/span>Global Minimum Tax Faces Chinese Opposition<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Internationally, China is leading objections to a potential move by former President Trump to reprieve the global minimum tax. This stance highlights ongoing geopolitical tensions surrounding international corporate taxation policies.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Citigroup_Upgrades_Thermo_Fisher_Scientific\"><\/span>Citigroup Upgrades Thermo Fisher Scientific<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>In analyst news, Citigroup has upgraded Thermo Fisher Scientific (<a href=\"\/stock\/TMO\">TMO<\/a>) to a &#39;Buy&#39; rating from &#39;Neutral&#39;. The firm also raised its price target for the scientific instrument maker to $660 from $580.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Market_Overview\"><\/span>Market Overview<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>European bourses opened lower but later showed marginal firmness, while US equity futures were in the red, with underperformance noted in the Nasdaq following Oracle&#39;s (-11%) earnings report. <em>The DXY initially attempted to pare post-FOMC pressure but is now flat, with the Swiss Franc showing little movement.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Eli Lilly&#39;s (LLY) experimental obesity drug, Retatrutide, demonstrated significant weight loss, with participants losing an average of 28.7% [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[15715,6255,6334,6761,7815,8412,9443,10922,12787,15714],"class_list":["post-57114","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-obesity-drug","tag-clinical-trials","tag-novo-nordisk","tag-eli-lilly","tag-altria","tag-pharmaceutical","tag-weight-loss","tag-ceo-succession","tag-global-minimum-tax","tag-retatrutide"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/57114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=57114"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/57114\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=57114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=57114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=57114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}